EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Enhancing Lipid Nanoparticle-Mediated Circular RNA and mRNA Expression in the Placenta through Inhibition of IFNAR-JAK-STAT Signaling

Hannah C Safford iD, Hannah C Geisler iD, Ajay S Thatte iD, Kuo-Chieh Liao, Alexandre Poirier, Marshall Padilla, Hannah M Yamagata iD, Anushka Agrawal iD, Amanda M Murray iD, Alex G Hamilton, Kelsey L Swingle iD, Emily Fitzgerald und 3 weitere

Nano Letters · 2026

DOI: 10.1021/acs.nanolett.6c01762 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nano Letters, 2026. Verfasst von Hannah C Safford und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania19104, United States. Hauptthemen laut MEDLINE: Placenta, RNA, Messenger, Nanoparticles, Receptor, Interferon alpha-beta. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science Foundation, National Institutes of Health (NIH) Director's New Innovator Award, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The placenta has emerged as a promising target for RNA lipid nanoparticle (LNP)-based therapies to treat obstetric complications, yet efficient extrahepatic RNA transfection remains a challenge. Here, we identify innate immune signaling as a regulator of placental RNA translation and demonstrate that inhibition of IFN-α/β receptor (IFNAR) and JAK-STAT signaling enhances LNP-mediated transgene expression in the placenta for both messenger RNA (mRNA) and circular RNA (circRNA). While a placenta-tropic LNP enabled robust and durable circRNA expression in trophoblasts in vitro, circRNA translation was substantially decreased in vivo compared to mRNA in pregnant mice. Inhibition of IFNAR-JAK-STAT signaling enhanced circRNA translation up to 12-fold in maternal organs and increased circRNA and mRNA translation in the placenta up to 17.5- and 4-fold, respectively. JAK-STAT inhibition also enhanced translation of therapeutically relevant VEGF-encoding circRNA and mRNA in pregnant mice, suggesting innate immune modulation as a broadly applicable strategy to improve RNA therapeutics during pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlacentaRNA, MessengerNanoparticlesReceptor, Interferon alpha-betaRNA, CircularFemalePregnancyAnimalsMiceSignal TransductionJanus KinasesLipidsSTAT Transcription FactorsImmunity, InnateHumansLiposomes

Stichwörter der Autor:innen

circular RNAinnate immune signalinglipid nanoparticlesmRNAplacenta

Substanzen

RNA, MessengerJanus KinasesReceptor, Interferon alpha-betaRNA, CircularLipidsLipid NanoparticlesSTAT Transcription FactorsLiposomes

Autor:innen und Institutionen

  • Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania19104, United States.
  • Genome Institute of Singapore, Agency for Science, Technology, and Research (A*STAR), Singapore138672, Singapore.
  • Penn Institute for RNA Innovation, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania19104, United States.
  • Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania19104, United States.
  • Institute for Immunology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania19104, United States.
  • Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania19014, United States.

ORCID-Profile: Hannah C Safford, Hannah C Geisler, Ajay S Thatte, Hannah M Yamagata, Anushka Agrawal, Amanda M Murray, Kelsey L Swingle, Michael J Mitchell

Förderung

  • National Science Foundation
  • National Institutes of Health (NIH) Director's New Innovator Award
  • NICHD NIH HHS
  • Burroughs Wellcome Fund Career Award at the Scientific Interface
  • National Institutes of Health (NICHD R01 HD115877)
  • American Cancer Society Research Scholar Grant
  • National Science Foundation (NSF) CAREER Award

Zitieren

APA

Safford, H. C., Geisler, H. C., Thatte, A. S., Liao, K. C., Poirier, A., Padilla, M., Yamagata, H. M., Agrawal, A., Murray, A. M., Hamilton, A. G., Swingle, K. L., Fitzgerald, E., Chalom, O., Wan, Y., & Mitchell, M. J. (2026). Enhancing Lipid Nanoparticle-Mediated Circular RNA and mRNA Expression in the Placenta through Inhibition of IFNAR-JAK-STAT Signaling. Nano Letters. https://doi.org/10.1021/acs.nanolett.6c01762

Vancouver

Safford HC, Geisler HC, Thatte AS, Liao KC, Poirier A, Padilla M, et al. Enhancing Lipid Nanoparticle-Mediated Circular RNA and mRNA Expression in the Placenta through Inhibition of IFNAR-JAK-STAT Signaling. Nano Letters. 2026. doi:10.1021/acs.nanolett.6c01762

BibTeX
@article{Safford2026,
  author = {Safford, Hannah C and Geisler, Hannah C and Thatte, Ajay S and Liao, Kuo-Chieh and Poirier, Alexandre and Padilla, Marshall and Yamagata, Hannah M and Agrawal, Anushka and Murray, Amanda M and Hamilton, Alex G and Swingle, Kelsey L and Fitzgerald, Emily and Chalom, Ori and Wan, Yue and Mitchell, Michael J},
  title = {Enhancing Lipid Nanoparticle-Mediated Circular RNA and mRNA Expression in the Placenta through Inhibition of IFNAR-JAK-STAT Signaling},
  journal = {Nano Letters},
  year = {2026},
  doi = {10.1021/acs.nanolett.6c01762}
}
Kostenlos starten →